Terms: = Lymphoma AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
34 results:
1. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
Kondo N; Utsumi T; Shimizu Y; Takemoto A; Oh-Hara T; Uchibori K; Subat-Motoshi S; Ninomiya H; Takeuchi K; Nishio M; Miyazaki Y; Katayama R
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917191
[TBL] [Abstract] [Full Text] [Related]
2. Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.
Eraky AM; Beck RT; Treffy RW; Aaronson DM; Hedayat H
J Integr Neurosci; 2023 May; 22(3):73. PubMed ID: 37258452
[TBL] [Abstract] [Full Text] [Related]
3. Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases.
Miao Y; Zhang J; Chen Q; Xing L; Qiu T; Zhu H; Wang L; Fan L; Xu W; Li J
Front Immunol; 2022; 13():970183. PubMed ID: 36032133
[TBL] [Abstract] [Full Text] [Related]
4. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
[TBL] [Abstract] [Full Text] [Related]
5. Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!
Cordier F; Van der Meulen J; van Roy N; De Wilde J; van Dijck H; Vanhoenacker F; Lambrechts M; Noyez V; Van de Vijver K; Ferdinande L; Dendooven A; Van Dorpe J; Creytens D
Pathol Res Pract; 2022 Mar; 231():153772. PubMed ID: 35074700
[TBL] [Abstract] [Full Text] [Related]
6. A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin lymphoma.
Feng Z; Gao J; Gao X; Hua L; Nie X; Sun Y; Wang M
Drug Des Devel Ther; 2021; 15():4575-4583. PubMed ID: 34764639
[TBL] [Abstract] [Full Text] [Related]
7. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.
Usman RM; Razzaq F; Akbar A; Farooqui AA; Iftikhar A; Latif A; Hassan H; Zhao J; Carew JS; Nawrocki ST; Anwer F
Asia Pac J Clin Oncol; 2021 Jun; 17(3):193-208. PubMed ID: 32970929
[TBL] [Abstract] [Full Text] [Related]
8. Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies.
Leng S; Moshier E; Tremblay D; Hu L; Biran N; Barman N; Parekh S; Cho H; Madduri D; Richter J; Barlogie B; Jagannath S; Chari A
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e734-e751. PubMed ID: 32660906
[TBL] [Abstract] [Full Text] [Related]
9. Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling.
Dent P; Booth L; Poklepovic A; Martinez J; Hoff DV; Hancock JF
J Cell Physiol; 2020 Nov; 235(11):7889-7899. PubMed ID: 31912905
[TBL] [Abstract] [Full Text] [Related]
10. Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.
Recondo G; Mezquita L; Facchinetti F; Planchard D; Gazzah A; Bigot L; Rizvi AZ; Frias RL; Thiery JP; Scoazec JY; Sourisseau T; Howarth K; Deas O; Samofalova D; Galissant J; Tesson P; Braye F; Naltet C; Lavaud P; Mahjoubi L; Abou Lovergne A; Vassal G; Bahleda R; Hollebecque A; Nicotra C; Ngo-Camus M; Michiels S; Lacroix L; Richon C; Auger N; De Baere T; Tselikas L; Solary E; Angevin E; Eggermont AM; Andre F; Massard C; Olaussen KA; Soria JC; Besse B; Friboulet L
Clin Cancer Res; 2020 Jan; 26(1):242-255. PubMed ID: 31585938
[TBL] [Abstract] [Full Text] [Related]
11. Monsanto, PCBs, and the creation of a "world-wide ecological problem".
Markowitz G; Rosner D
J Public Health Policy; 2018 Nov; 39(4):463-540. PubMed ID: 30401808
[TBL] [Abstract] [Full Text] [Related]
12. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
[TBL] [Abstract] [Full Text] [Related]
13. Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.
Attwa MW; Darwish HW; Alhazmi HA; Kadi AA
Clin Chim Acta; 2018 Oct; 485():298-304. PubMed ID: 30006284
[TBL] [Abstract] [Full Text] [Related]
14. Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometry.
Darwish HW; Kadi AA; Attwa MW; Almutairi HS
Clin Chim Acta; 2018 May; 480():180-185. PubMed ID: 29458050
[TBL] [Abstract] [Full Text] [Related]
15. Infusion of autograft natural killer cell/CD14
Kansagra A; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN; Porrata LF
Bone Marrow Transplant; 2018 Feb; 53(2):146-154. PubMed ID: 29035394
[TBL] [Abstract] [Full Text] [Related]
16. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract] [Full Text] [Related]
17. PAR1‑mediated c‑Jun activation promotes heat stress‑induced early stage apoptosis of human umbilical vein endothelial cells.
Zhang S; Liu Y; Wang Z; Liu J; Gu Z; Xu Q; Su L
Mol Med Rep; 2017 May; 15(5):2595-2603. PubMed ID: 28447716
[TBL] [Abstract] [Full Text] [Related]
18. 15α-methoxypuupehenol Induces Antitumor Effects
Hilliard TS; Miklossy G; Chock C; Yue P; Williams P; Turkson J
Mol Cancer Ther; 2017 Apr; 16(4):601-613. PubMed ID: 28069875
[TBL] [Abstract] [Full Text] [Related]
19. Subclinical Hypothyroidism in Childhood Cancer Survivors.
Lee HJ; Hahn SM; Jin SL; Shin YJ; Kim SH; Lee YS; Kim HS; Lyu CJ; Han JW
Yonsei Med J; 2016 Jul; 57(4):915-22. PubMed ID: 27189285
[TBL] [Abstract] [Full Text] [Related]
20. Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.
Ugurluer G; Chang K; Gamez ME; Arnett AL; Jayakrishnan R; Miller RC; Sio TT
Anticancer Res; 2016 May; 36(5):2331-8. PubMed ID: 27127140
[TBL] [Abstract] [Full Text] [Related]
[Next]
